Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024

  1. LumiraDx Limited

    World Rank (Jan-05-2024)
    16,811
    Market Cap (Jan-05-2024)
    0.247 Billion USD
    World Rank (Jul-30-2023)
    17,990
    Market Cap (Jul-30-2023)
    0.202 Billion USD
    World Rank (Dec-25-2022)
    16,026
    Market Cap (Dec-25-2022)
    0.286 Billion USD
    Headquarters Country
  2. Atara Biotherapeutics

    World Rank (Jan-05-2024)
    25,337
    Market Cap (Jan-05-2024)
    0.046 Billion USD
    World Rank (Jul-30-2023)
    17,991
    Market Cap (Jul-30-2023)
    0.202 Billion USD
    World Rank (Dec-25-2022)
    16,070
    Market Cap (Dec-25-2022)
    0.284 Billion USD
    World Rank (Jan-07-2022)
    7,703
    Market Cap (Jan-07-2022)
    1.41 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Net Income in USD
    -340 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Atara Biotherapeutics is a off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. It is estimated that the annual revenue is currently $36M per year and has 450 Employees as on 2019. The headquarters is in USA.
  3. Adaptimmune Therapeutics

    World Rank (Jan-05-2024)
    17,897
    Market Cap (Jan-05-2024)
    0.200 Billion USD
    World Rank (Jul-30-2023)
    18,058
    Market Cap (Jul-30-2023)
    0.200 Billion USD
    World Rank (Dec-25-2022)
    17,423
    Market Cap (Dec-25-2022)
    0.223 Billion USD
    World Rank (Jan-07-2022)
    12,831
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Net Income in USD
    -186 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  4. Absci Corp

    World Rank (Jan-05-2024)
    14,874
    Market Cap (Jan-05-2024)
    0.346 Billion USD
    World Rank (Jul-30-2023)
    18,130
    Market Cap (Jul-30-2023)
    0.197 Billion USD
    World Rank (Dec-25-2022)
    18,001
    Market Cap (Dec-25-2022)
    0.200 Billion USD
    World Rank (Jan-07-2022)
    11,637
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    4 Million USD
    Annual Net Income in USD
    -103 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  5. Immutep

    World Rank (Jan-05-2024)
    4,548
    Market Cap (Jan-05-2024)
    2.850 Billion USD
    World Rank (Jul-30-2023)
    18,237
    Market Cap (Jul-30-2023)
    0.193 Billion USD
    World Rank (Dec-25-2022)
    18,715
    Market Cap (Dec-25-2022)
    0.176 Billion USD
    World Rank (Jan-07-2022)
    17,547
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Net Income in USD
    -13 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Stock Category
  6. Vor Biopharma Inc.

    World Rank (Jan-05-2024)
    19,708
    Market Cap (Jan-05-2024)
    0.141 Billion USD
    World Rank (Jul-30-2023)
    18,336
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    World Rank (Dec-25-2022)
    12,953
    Market Cap (Dec-25-2022)
    0.460 Billion USD
    World Rank (Jan-07-2022)
    14,870
    Market Cap (Jan-07-2022)
    0.40 Billion USD
    Headquarters Country
  7. NGM Biopharmaceuticals

    World Rank (Jan-05-2024)
    21,519
    Market Cap (Jan-05-2024)
    0.098 Billion USD
    World Rank (Jul-30-2023)
    18,338
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    World Rank (Dec-25-2022)
    14,007
    Market Cap (Dec-25-2022)
    0.393 Billion USD
    World Rank (Jan-07-2022)
    8,022
    Market Cap (Jan-07-2022)
    1.32 Billion USD
    Annual Revenue in USD
    77 Million USD
    Annual Net Income in USD
    -120 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    NGM Biopharmaceuticals is a Clinical Stage Biopharmaceutical company. It is focused on harnessing powerful, untapped biology underlying major diseases to develop transformative therapeutics for patients and focus include cardio metabolic, liver, oncologic and ophthalmic diseases. The headquarters is in USA.

  8. Inotiv Inc.

    World Rank (Jan-05-2024)
    21,273
    Market Cap (Jan-05-2024)
    0.103 Billion USD
    World Rank (Jul-30-2023)
    18,360
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    World Rank (Dec-25-2022)
    20,296
    Market Cap (Dec-25-2022)
    0.130 Billion USD
    Headquarters Country
  9. Fibrogen

    World Rank (Jan-05-2024)
    22,635
    Market Cap (Jan-05-2024)
    0.079 Billion USD
    World Rank (Jul-30-2023)
    18,401
    Market Cap (Jul-30-2023)
    0.187 Billion USD
    World Rank (Dec-25-2022)
    6,648
    Market Cap (Dec-25-2022)
    1.467 Billion USD
    World Rank (Jan-07-2022)
    8,306
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    235 Million USD
    Annual Net Income in USD
    -290 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    FibroGen is a Biotechnology company. It collaborating on the development and commercialization of roxadustat for the treatment of anemia in territories including Japan, Europe, the Commonwealth of Independent States, the Middle East and South Africa. The headquarters is in USA.

Share

Ads